Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2024

Next generation cell cycle inhibitors and role of biomarker selection

Is there a role for biomarker selection for CDK4/6 inhibitors?

Date

28 Feb 2024

Session

Next generation cell cycle inhibitors and role of biomarker selection

Topics

Clinical Research;  Translational Research;  Endocrine Therapy;  Pathology/Molecular Biology;  Targeted Therapy;  Genetic and Genomic Testing

Tumour Site

Breast Cancer

Presenters

Stacy Moulder

Authors

S. Moulder

Author affiliations

  • The University of Texas M. D. Anderson Cancer Center, 77030 - Houston/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Presenter: All Speakers

Session: Next generation cell cycle inhibitors and role of biomarker selection

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.